Early detection (≥ 300-500 mL), the MOTIVE bundle with tranexamic acid, second-line uterotonics, balloon tamponade, surgery and massive transfusion.
At the bedside
Timed steps- 1
Detect early
0 minMeasure blood loss objectively (calibrated drape, weighing); monitor vital signs and shock index (> 0.9-1 concerning).
- 2
MOTIVE bundle immediately
≤ 15 minMassage of the uterus; Oxytocic (oxytocin 10 units IV/IM + infusion); Tranexamic acid 1 g IV; IV fluids (warmed crystalloid, blood); Vaginal and genital tract examination (tears, retained tissue); Escalation.
- 3
Second-line uterotonics
Carboprost 250 mcg IM every 15 min (not in asthma), methylergometrine 0.2 mg IM (not in hypertension), misoprostol 800 mcg SL.
- 4
Call for help and blood
Activate obstetric haemorrhage/massive transfusion protocol; group-specific/O-negative blood; FFP, platelets; keep fibrinogen > 200 mg/dL (cryoprecipitate/fibrinogen concentrate) - fibrinogen < 200 predicts severe PPH.
- 5
Mechanical and surgical
Bimanual compression, uterine balloon tamponade (Bakri or condom catheter), non-pneumatic anti-shock garment during transfer; laparotomy with compression sutures (B-Lynch), uterine/internal iliac artery ligation, interventional radiology embolisation, hysterectomy.
- 6
Correct the lethal triad
Warm fluids and patient, ionised Ca > 1.1 mmol/L, avoid acidosis; viscoelastic testing where available.
- 7
After PPH
HDU/ICU monitoring for re-bleeding, DIC, AKI, Sheehan's; IV iron for anaemia; VTE prophylaxis once bleeding controlled.
First-line uterotonic
Oxytocin
- Dose
- 10 units slow IV/IM, then 40 units in 500 mL at 125 mL/h
- Worked example
- 10 units/h = 125 mL/h of 40 units/500 mL
All PPH
Tranexamic acid
- Dose
- 1 g over 10 min; repeat 1 g after 30 min if bleeding continues
- Worked example
- 1 g (10 mL of 100 mg/mL) in 100 mL NS over 10 min
Refractory atony
Carboprost (15-methyl PGF2α)
- Dose
- 250 mcg every 15 min (max 2 mg)
Adjunct uterotonic
Misoprostol
- Dose
- 800 mcg once
Atony without hypertension
Methylergometrine (ergometrine)
- Dose
- 0.2 mg, may repeat after 15 min
Calculators for this topic
References
- 1
- 2
- 3
- 4
- 5
PPH: first response
Step 1 of ~6
MOTIVE: massage, oxytocin, TXA 1 g, IV fluids, examine
Based on World Health Organization, FIGO, ICM; Mavrides E, Allard S, Chandraharan E, et al. Educational use; follow local protocol.
Pathophysiology
At term, uterine blood flow is ~700 mL/min; haemostasis depends on myometrial contraction compressing spiral arteries. Atony, trauma or coagulopathy (abruption, AFE, sepsis, dilution) cause rapid haemorrhage; hypofibrinogenaemia develops early.
Evidence
- WOMAN (20,060 women): TXA reduced death from bleeding (1.5% vs 1.9%), especially within 3 h [WOMAN 2017].
- E-MOTIVE: calibrated drape detection plus bundle reduced severe PPH, laparotomy or death (1.6% vs 4.3%) [Gallos 2023].
- WHO/FIGO/ICM 2025 consolidated PPH guidelines [WHO 2025].
Controversies
- Prophylactic TXA at caesarean; fibrinogen concentrate vs cryoprecipitate; REBOA.
🇮🇳 India notes
- PPH is the leading cause of maternal death in India; anaemia in pregnancy reduces tolerance to blood loss.
- Condom-catheter balloon tamponade is a low-cost option; carbetocin (heat-stable) and misoprostol are useful where cold chain is unreliable.
- MoHFW programmes (LaQshya, SUMAN) promote PPH drills and blood availability at first referral units.
References
- 1
- 2
- 3
- 4
- 5
Test yourself
Module quiz · score 70% to complete the module
Educational reference for trained clinicians. Check doses against your hospital protocol and the patient in front of you.

